| Literature DB >> 23206553 |
Nicola L M Paul1, Michela Simoni, Peter M Rothwell.
Abstract
BACKGROUND: Transient isolated brainstem symptoms (eg, isolated vertigo, dysarthria, diplopia) are not consistently classified as transient ischaemic attacks (TIAs) and data for prognosis are limited. If some of these transient neurological attacks (TNAs) are due to vertebrobasilar ischaemia, then they should be common during the days and weeks preceding posterior circulation strokes. We aimed to assess the frequency of TNAs before vertebrobasilar ischaemic stroke.Entities:
Mesh:
Year: 2012 PMID: 23206553 PMCID: PMC3530272 DOI: 10.1016/S1474-4422(12)70299-5
Source DB: PubMed Journal: Lancet Neurol ISSN: 1474-4422 Impact factor: 44.182
Baseline characteristics, vascular risk factors, and premorbid medication in patients with definite ischaemic stroke, by territory
| Mean age (years) | 75·9 (11·8) | 73·3 (13·1) | 0·002 |
| Male sex | 372 (49%) | 133 (48%) | 0·88 |
| Hypertension | 450 (59 %) | 173 (63%) | 0·31 |
| Diabetes | 85 (11 %) | 35 (13%) | 0·51 |
| Angina or myocardial infarction | 145 (19%) | 64 (23%) | 0·16 |
| Peripheral vascular disease | 59 (8%) | 28 (10%) | 0·25 |
| Previously diagnosed atrial fibrillation | 156 (21%) | 50 (18%) | 0·43 |
| Current smoker | 107 (14%) | 34 (12%) | 0·54 |
| Previous TIA | 65 (9%) | 20 (7%) | 0·61 |
| Previous stroke | 126 (17%) | 33 (12%) | 0·08 |
| Previous antiplatelet treatment | 336 (44%) | 109 (40%) | 0·20 |
| Previous statin treatment | 168 (22%) | 61 (22%) | 1·0 |
| Previous antihypertensive treatment | 443 (58%) | 171 (62%) | 0·28 |
Data are number of patients (%) or mean (SD). TIA=transient ischaemic attack.
FigureOccurrence of vertebrobasilar TNA or TIA in the 90 days before vertebrobasilar stroke (A) versus occurrence of carotid TNA or TIA in the 90 days before carotid stroke (B)
TIA=transient ischaemic attack. TNA=transient neurological attack.
TNA or TIA in the 90 days preceding stroke by territory
| Vertebrobasilar | Carotid | ||||
|---|---|---|---|---|---|
| TNA in vertebrobasilar territory | 45/275 (16%) | 10/759 (1%) | 14·7 (7·3–29·5) | <0·0001 | |
| 0–2 days | 22/252 (9%) | 2/751 (<1%) | 35·8 (8·4–153·5) | <0·0001 | |
| 3–7 days | 4/256 (2%) | 2/753 (<1%) | 6·0 (1·1–32·7) | 0·04 | |
| 8–90 days | 19/275 (7%) | 6/759 (1%) | 9·3 (3·7–23·6) | <0·0001 | |
| TNA in uncertain territory | 9/225 (4%) | 17/717 (2%) | 1·7 (0·8–3·9) | 0·20 | |
| Definite TIA | 5/221 (3%) | 32/732 (4%) | 0·5 (0·2–1·3) | 0·16 | |
TNA=transient neurological attack. TIA=transient ischaemic attack. Data are n/N (%) unless otherwise stated.
Isolated vertigo, vertigo plus other symptoms of any type, isolated double vision, transient generalised weakness, and binocular visual disturbance. Days indicate the time of the transient event before the stroke event.
This association was independent of age: OR 12·8 (95% CI 3·6–45·9) for ages <65 years; OR 14·7 (7·3–29·5) for ages 65–74 years; and OR 11·0 (4·6–26·4) for ages ≥75 years.
Isolated slurred speech, migraine variant, transient confusion, and isolated hemisensory tingling. Denominators are based on first TNA or TIA during the 90 days preceding stroke; therefore patients with TNAs or TIAs during the initial period were censored.
Vascular risk factors and duration of isolated vertigo versus other vertebrobasilar TNAs preceding vertebrobasilar stroke
| Age ≥60 years | 17 (74%) | 15 (68%) | |
| Any vascular risk factors (diabetes mellitus, hypertension, smoking, or atrial fibrillation) | 19 (83%) | 11 (50%) | |
| Previous vascular events (myocardial infarction, peripheral vascular disease, TIA, or stroke) | 4 (17%) | 9 (41%) | |
| Any vascular medication | 12 (52%) | 17 (77%) | |
| Duration of symptoms | |||
| <1 h | 11 (48%) | 15 (68%) | |
| ≥1 h | 12 (52%) | 7 (32%) | |
Data are number of patients (%) unless otherwise stated. TNA=transient neurological attack. TIA=transient ischaemic attack.
Any antiplatelet, statin, or antihypertensive.
Events in the 90 days preceding ischaemic stroke or TIA with ≥50% symptomatic stenosis
| Vertebrobasilar stenosis (n=39) | Carotid stenosis (n=45) | OR (95% CI) | p value | Vertebrobasilar stenosis (n=72) | Carotid stenosis (n=95) | OR (95% CI) | p value | |
|---|---|---|---|---|---|---|---|---|
| NINDS TIA | 1 (3%) | 4 (9%) | 0·27 (0·01–2·8) | 0·37 | 5 (7%) | 17 (18%) | 0·3 (0·1–1·1) | 0·04 |
| TNA | 11 (28%) | 3 (7%) | 5·50 (1·3–27·6) | 0·02 | 27 (38%) | 12 (13%) | 4·2 (1·8–9·7) | 0·002 |
| No TIA or TNA | 27 (69%) | 38 (84%) | 0·41 (0·1–1·3) | 0·12 | 40 (56%) | 66 (69%) | 0·5 (0·3–1·1) | 0·08 |
Data are n (%) unless otherwise stated. TNA=transient neurological attack. TIA=transient ischaemic attack. OR=odds ratio. NINDS=National Institute of Neurological and Disorders and Stroke. Vascular evaluation was done using CT, MRI, or catheter angiography as clinically appropriate. Stenosis was defined as 50% or greater symptomatic stenosis. Derived from a total of 873 strokes with vascular imaging and 83 TIAs with 50% or greater symptomatic stenosis.